Amgen (AMGN) Tops Q1 EPS by 15c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq hits record high as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mail_58cbc46cd3c33.jpg)
Get Alerts AMGN Hot Sheet
Price: $402.24 -0.2%
EPS Growth %: +2.7%
Financial Fact:
Total revenues: 5.81B
Today's EPS Names:
VFS, PKE, More
EPS Growth %: +2.7%
Financial Fact:
Total revenues: 5.81B
Today's EPS Names:
VFS, PKE, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q1 EPS of $3.15, $0.15 better than the analyst estimate of $3.00. Revenue for the quarter came in at $5.5 billion versus the consensus estimate of $5.61 billion.
GUIDANCE:
Amgen sees FY2017 EPS of $12.00-$12.60, versus the consensus of $12.33. Amgen sees FY2017 revenue of $22.3-23.1 billion, versus the consensus of $23 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amgen (AMGN) Reiterated at Neutral by Cantor Fitzgerald
- StoneX Reiterates Buy Rating on Cinemark Holdings (CNK)
- Insmed stock falls as CFO Sara Bonstein to step down
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
